Adagio Medical Appoints Two Seasoned Senior Executives to Accelerate Commercial Readiness 
GelStat Forms New and Advanced Engineering Division
GSAC Engineering Marks the First Phase of a Turnaround Plan to Drive its Corporate Growth StrategySTUART, Fla., March 07, 2023...
Veru to Present at the Oppenheimer 33rd Annual Healthcare Conference
MIAMI, FL., March 07, 2023 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines...
University of Alabama at Birmingham Reaches 1,000 Patient Pulmonary Exams With Dynamic Digital Radiography
Dynamic Digital Radiography Dynamic Digital Radiography is an enhanced X-ray technology that enables clinicians to analyze and quantify the dynamic...
Better Choice and Pet Supermarket Announce Partnership
Pet Supermarket will Offer Halo Brand in 75 Retail Stores in the USA Halo Products Now Offered in 1500+ Retail...
PM Consulting Group Changes Name to Vistant
One of the Fastest Growing Companies in Washington, DC, and Baltimore, Rebrands and Reaffirms Commitment To Helping Solve Complex Global...
Assertio Appoints Dr. Howard Franklin as Senior Vice President, Medical
LAKE FOREST, Ill., March 06, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a specialty...
Smile Health Orthodontics (SHO) Now Offering In-Office Spectralase Diode Laser Treatment
Treatments are comfortable, highly effective and with a fast recovery Patient undergoing gingival recontouring laser treatment with Spectralase at Smile...
Inovalon Announces Converged Outreach
The Industry’s Only SaaS Solution for the Coordination of Multiple Concurrent Patient Engagement Initiatives to Optimize Impact and EfficiencyBOWIE, Md.,...
Clinical evidence presented at ACC.23/WCC highlights how utilization of Philips cardiology solutions is improving the quality and efficiency of patient care
Philips Intracardiac Echocardiography Catheter – VeriSight Pro Intravascular ultrasound (IVUS) catheter CIED infection March 6, 2023 Preliminary results of large-scale...
Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2022 Financial Results on March 21, 2023
GUILFORD, Conn., March 06, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the...
AIM ImmunoTech Issues Letter to Stockholders
Year marked by noteworthy operational execution and clinical development progress across pipeline Company reiterates commitment to continued communication and activity...
IRADIMED CORPORATION To Present at the 35th Annual Roth Conference
WINTER SPRINGS, Fla., March 06, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) today announced that Roger Susi,...
Longeveron to Announce Fourth Quarter and Full Year Financial Results on March 10, 2023
Live conference call on Friday, March 10 at 8:30 a.m. ETMIAMI, March 06, 2023 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ:...
Relievant Medsystems Announces Positive Local Coverage Determination by Palmetto GBA for Basivertebral Nerve Ablation in Treating Chronic Vertebrogenic Low Back Pain
MINNEAPOLIS, March 06, 2023 (GLOBE NEWSWIRE) -- Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of vertebrogenic...
Bellerophon Therapeutics Announces $5 Million Registered Direct Offering
WARREN, N.J., March 06, 2023 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics...
Surgalign Provides Update on Corporate Restructuring Initiatives and Confirms its Prior 2022 Revenue Guidance
Company on track to achieve target cash savings of $30 - $35 million in 2023 vs 2022; expects to report...
Anti-Properdin Antibody (NM3086) Demonstrates Efficacy in a Primate Model of Wet-AMD and Dry-AMD
Figure 1 Fluoresceine angiogram data from three animals treated with NM3086 (bottom) and three that received placebo control. The picture...
Mineralys Therapeutics Presents Positive Lorundrostat Results from the Phase 2 Target-HTN Trial at ACC.23/WCC
Lorundrostat demonstrated clinically meaningful blood pressure reduction in individuals with uncontrolled hypertension Obesity was predictive of an enhanced response to...
89bio Presents New Analysis of Data from Phase 2 ENTRIGUE Trial of Pegozafermin in Patients with Severe Hypertriglyceridemia (SHTG) at American College of Cardiology’s Annual Scientific Session Together with World Congress of Cardiology
– Post hoc analysis data demonstrated pegozafermin treatment significantly reduced triglycerides and other atherogenic lipids in patients with SHTG regardless...
New Analyses of Sotagliflozin Showing Time to Clinical Benefit Presented at The American College of Cardiology’s 72nd Annual Scientific Session Together With World Heart Federation’s World Congress of Cardiology
Statistically significant reduction in the risk for the primary outcome on Day 27 Findings generally consistent across the left ventricular...